Related Experiment Videos
The P9 peptide sidechain specificity of I-Ad
1Department of Immunology, Institute of Medical Biology, University of Tromsø, School of Medicine, Norway. bartne@online.no
Immunology Letters
|February 3, 2000
Summary
The P9 pocket of the I-Ad molecule primarily accepts small, uncharged sidechains, influencing autoimmune disease susceptibility. This specificity explains why certain IgG2a allotypes confer protection against herpes simplex virus (HSV)-induced keratitis and type 1 diabetes.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- The murine MHC class II variant I-Ad influences susceptibility to herpes simplex virus (HSV)-induced keratitis and type 1 diabetes.
- The peptide-binding groove's P9 pocket is critical for determining T-cell responses and autoimmune disease associations.
Purpose of the Study:
- To analyze the peptide sidechain specificity of the I-Ad P9 pocket.
- To understand how P9 pocket interactions influence T-cell responses and autoimmune disease susceptibility.
Main Methods:
- Assessment of T-cell responses to modified peptides.
- Analysis of I-Ad binding capacity with position 446-substituted analogs of IgG2a heavy chain peptides.
- Comparison of I-Ad and I-Ag7 P9 pocket specificities.
Main Results:
- Engagement of the P9 pocket is crucial for peptide presentation, with sidechain size, not charge, determining binding.
- Small, uncharged sidechains are favored, while acidic, aromatic, lysine, and arginine residues are disfavored.
- I-Ad (Serine beta57) specificity differs from I-Ag7 (Aspartic acid beta57), impacting diabetes susceptibility.
- Susceptibility to HSV keratitis in IgG2a(a) mice is linked to inefficient thymic presentation of autologous IgG2a due to P9 pocket binding limitations.
Conclusions:
- Polymorphism at residue beta57 significantly affects autoimmune disease susceptibility through P9 pocket specificity.
- The P9 pocket's size-selectivity explains differential susceptibility to HSV keratitis and protection against type 1 diabetes conferred by IgG2a allotypes.